Role of T-cells in the development of arthritis

Clinical Science

Volumn 95, Issue 1, 1998, Pages 19-31

  Gaston, J S H ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Adjuvant; Autoantigen; Autoimmunity; Rheumatoid arthritis; Synovitis; T cells

Indexed keywords

ANTIGEN; AUTOANTIGEN; BCG VACCINE; COLLAGEN TYPE 2; EPITOPE; HEAT SHOCK PROTEIN 60; T LYMPHOCYTE RECEPTOR;

ADJUVANT ARTHRITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BCG VACCINATION; BLADDER CANCER; CELL POPULATION; CHLAMYDIA TRACHOMATIS; DISEASE SEVERITY; HEREDITY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOREGULATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REACTIVE ARTHRITIS; REVIEW; RHEUMATOID ARTHRITIS; T LYMPHOCYTE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, INFECTIOUS; ARTHRITIS, RHEUMATOID; AUTOANTIGENS; CHAPERONIN 60; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOTHERAPY; MICE; T-LYMPHOCYTES;

EID: 0031876414     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS19980017     Document Type: Review

References (116)

1. Janossy, G., Duke, O., Poulter, L. W., Panayi, G., Bofill, M. and Goldstein, G. (1981) Rheumatoid arthritis: a disease of T-lymphocyte/macrophage immunoregulation. Lancet ii: 839-842
2. Panayi, G. S., Lanchbury, J. S. and Kingsley, G. H. (1992) The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum. 35, 729-735
3. Gaston, J. (1993) Synovial lymphocytes and the aetiology of synovitis. Ann. Rheum. Dis. 52 (Suppl. 1), S17-S21
4. Salmon, M. and Gaston, J. S. H. (1995) The role of T-lymphocytes in rheumatoid arthritis. Br. Med. Bull. 51, 332-345
5. Firestein, G. S. and Zvaifler, N. J. (1993) The role of T-cells in rheumatoid arthritis. Ann. Rheum. Dis. 52, 765
6. Zvaifler, N. J. and Firestein, G. S. (1994) Pannus and pannocytes - alternative models of joint destruction in rheumatoid arthritis. Arthritis Rheumatism 37, 783-789
7. Elliott, M. J., Maini, R. N., Feldmann, M. et al. (1994) Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet 344, 1105-1110
8. Campion, G., Lebsack, M., Lookabaugh, J., Gordon, G. and Catalano, M. (1996) Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Arthritis Rheum. 39, 1092-1106
9. Tak, P. P., Vanderlubbe, P. A., Cauli, A., et al. (1995) Reduction of synovial inflammation after anti-CD4 monoclonal antibody treatment in early rheumatoid arthritis. Arthritis Rheum. 38, 1457-1465
10. Vanderlubbe, P. A., Dijkmans, B. A. C., Markusse, H. M., Nassander, U. and Breedveld, F. C. (1995) A randomized, double-blind, placebo-controlled study of CD4 monoclonal antibody therapy in early rheumatoid arthritis. Arthritis Rheum. 38, 1097-1106
11. Ladel, C. H., Blum, C., Dreher, A., Reifenberg, K. and Kaufmann, S. H. E. (1995) Protective role of gamma/delta T cells and alpha/beta T cells in tuberculosis. Eur. J. Immunol. 25, 2877-2881
12. Chin, P. and Hopewell, M. (1996) Mycobacterial complications of HIV infection. Clin. Chest Med. 17, 697-711
13. Cooper, A. M., Magram, J., Ferrante, J. and Orme, I. M. (1997) Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J. Exp. Med. 186, 39-45
14. Kamijo, R., Le, J., Shapiro, D. et al. (1993) Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guerin and subsequent challenge with lipopolysaccharide. J. Exp. Med. 178, 1435-1440
15. Jouanguy, E., Altare, F., Lamhamedi, S. et al. (1996) Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N. Engl. J. Med. 335, 1956-1961
16. Altare, F., Lammas, D., Revy, P., et al. (1998) Inherited interleukin-12 deficiency in a child with Bacille CalmetteGuerin infection. Nat. Gen., in the press
17. 15b Altare, F., Lahamedi, S., Lammas, D., et al. (1998) IL-12 receptor deficiency selectively impairs mycobacterial immunity. Science, in the press
18. VandenBerg, W. B., VandePutte, L. D. A., Zwarts, W. A. and Joosten, L. A. B. (1984) Electrical charge of the antigen determines intra-articular antigen handling and chronicity of arthritis in mice. J. Clin. Invest. 74, 1850-1859
19. Mertz, A. K. H., Batsford, S. R., Curschellas, E., Kist, M. J. and Gondolf, K. B. (1991) Cationic Yersinia antigen-induced chronic allergic arthritis in rats. J. Clin. Invest. 87, 632-642
20. Keat, A., Thomas, B., Dixey, J., Osborn, M., Sonnex, C. and Taylor-Robmson, D. (1987) Chlamydia trachomatis and reactive arthritis - the missing link. Lancet i, 72-74
21. Granfors, K., Jalkanen, S., Lindberg, A. et al. (1990) Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet 335, 685-688
22. Granfors, K., Jalkanen, S., von Essen, R. et al. (1989) Yersinia antigens in synovial fluid cells from patients with reactive arthritis. N. Engl. J. Med. 320, 216-221
23. Granfors, K., Jalkanen, S., Toivanen, P. and Lindberg, A. (1992) Bacterial lipopolysaccharide in synovial fluid cells in Shigella triggered reactive arthritis. J. Rheumatol. 19, 500
24. Taylor-Robinson, D., Gilroy, C., Thomas, B. and Keat, A. (1992) Detection of Chlamydia trachomatis DNA in joints of reactive arthritis patients by polymerase chain reaction. Lancet 340, 81-82
25. Li, F., Bulbul, R., Schumacher, H. R., et al. (1996) Molecular detection of bacterial DNA in venereal-associated arthritis. Arthritis Rheum. 39, 950-958
26. Nocton, J. J., Dressier, F., Rutledge, B. J., Rys, P. N., Persing, D. H. and Steere, A. C. (1994) Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N. Engl. J. Med. 330, 229-234
27. Gerard, H., Schumancher, H., Rank, R. and Hudson, A. (1997) Chlamydia disseminates to the synovium after genital infection in an animal model of reactive arthritis. Arthritis Rheum. 40, S331
28. Whittum-Hudson, J., Gerard, H., Branigan, P., Schumacher, H. and Hudson, A. (1997) Presence and pathogenesis of Chlamydia trachomatis in synovium after ocular infection in mice. Arthritis Rheum. 40, S143
29. Schumacher, H., Arayssi, T., Branigan, P., et al. (1997) Surveying for evidence of synovial Chlamydia trachomatis by polymerase chain reaction (PCR). A study of 411 synovial biopsies and synovial fluids. Arthritis Rheum. 40, S270
30. Schumacher, H., Arayssi, T., Branigan, P. et al. (1997) PCR study for bacterial DNA in normal synovium. Arthritis Rheum. 40, S269
31. Mertz, A., Daser, A., Skurnik, M. et al. (1994) The evolutionarily conserved ribosomal protein L23 and the cationic urease beta-subunit of Yersinia enterocolitica O:3 belong to the immunodominant antigens in Yersinia-triggered reactive arthritis: implications for autoimmunity. Mol. Med. 1, 44-55
32. Probst, P., Hermann, E., Zumbuschenfelde, K. H. M. and Fleischer, B. (1993) Identification of the Yersinia enterocolitica urease beta-subunit as a target antigen for human synovial T-lymphocytes in reactive arthritis. Infect. Immun. 61, 4507-4509
33. Probst, P., Hermann, E., Zumbuschenfelde, K. H. M. and Fleischer, B. (1993) Multiclonal synovial T-cell response to Yersinia enterocolitica in reactive arthritis - the Yersinia 61-kDa heat-shock protein is not the major target antigen. J. Infect. Dis. 167, 385-391
34. Hassell, A. B., Reynolds, D. J., Deacon, M., Gaston, J. S. H. and Pearce, J. H. (1993) Identification of T-cell stimulatory antigens of Chlamydia trachomatis using synovial fluidderived T-cell clones. Immunology 79, 513-519
35. Gaston, J. S. H., Deane, K. H. O., Jecock, R. M. and Pearce, J. H. (1996) Identification of 2 Chlamydia trachomatis antigens recognized by synovial fluid T cells from patients with Chlamydia-induced reactive arthritis. J. Rheumatol. 23, 130-136
36. Goodall, J., Clements, S., Deane, K., Hassell, A. and Gaston, J. (1997) Recognition of Chlamydia trachomatis (CT) outer membrane protein 2 (OMP2) by a reactive arthritis synovial T cell clone. Arthritis Rheum. 41, S143
37. Deane, K., Jecock, R., Pearce, J. and Gaston, J. (1997) Identification and characterization of a DR4-restricted T cell epitope within chlamydia hsp60. Clin. Exp. Immunol. 109, 439-445
38. Simon, A. K., Seipelt, E. and Sieper, J. (1994) Divergent T-cell cytokine patterns in inflammatory arthritis. Proc. Natl. Acad. Sci. U.S.A. 91, 8562-8566
39. Yin, Z. H., Braun, J., Neure, L. et al. (1997) Crucial role of interleukin-10/interleukin-12 balance in the regulation of the type 2 T helper cytokine response in reactive arthritis. Arthritis Rheum. 40, 1788-1797
40. Schlaak, J., Hermann, E., Ringhoffer, M. et al. (1992) Predominance of Th1 type T cells in synovial fluid of patients with Yersinia induced reactive arthritis. Eur. J. Immunol. 22, 2771-2776
41. Cotter, T. W., Ramsey, K. H., Miranpuri, G. S., Poulsen, C. E. and Byrne, G. I. (1997) Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice. Infect. Immun. 65, 2145-2152
42. Sieper, J. and Braun, J. (1995) Pathogenesis of spondylarthropathies: persistent bacterial antigen, autoimmunity, or both ? Arthritis Rheum. 38, 1547-1554
43. Joosten, L., Lubberts, E., Durez, P., et al. (1997) Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum. 40, 249-260
44. Benjamin, R. and Parham, P. (1990) Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol. Today 11, 137-139
45. Gaston, J. S. H. (1990) How does HLA-B27 confer susceptibility to inflammatory arthritis ? Clin. Exp. Immunol. 82, 1-2
46. Feltkamp, T. E. W., Khan, M. A. and Decastro, J. A. L. (1996) The pathogenetic role of HLA-B27. Immunol. Today 17, 5-7
47. LeirisaloRepo, M., Skylv, G. and Kousa, M. (1987) Follow-up study of Reiter's disease and reactive arthritis. Factors influencing the natural course and the prognosis. Clin. Rheumatol. 6 (Suppl. 2), 73-82
48. Thomson, G., Chiu, B., De, R. D., Falk, J. and Inman, R. (1992) Immunoepidemiologv of post Salmonella reactive arthritis in a cohort of women. Clin. Immunol. Immunopathol. 64, 227-232
49. Hermann, E., Yu, D. T. Y., MeyerZumBuschcnfelde, K. H. and Fleischer, B. (1993) HLA-B27-restricted CD8 T-cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet 342, 646-650
50. Ugrinovic, S., Mertz, A., Wu, P., Braun, J. and Sieper, J. (1997) A single 60 kD heat shock protein (HSP)-derived nonapeptide of Yersinia is a target antigen for CD8 + HLA-B27 restricted T cells in reactive arthritis. Arthritis Rheum. 40, S258
51. Breban, M., Hammer, R. E., Richardson, J. A. and Taurog, J. D. (1993) Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment. J. Exp. Med. 178, 1607-1616
52. Khalil, A., Khare, S., Luthra, H. and David, C. (1997) HLA-B27 transgenic mice lacking CD4 gene have decreased incidence of spontaneous inflammatory disease. Arthritis Rheum. 40, S330
53. Breban, M., Fernandezsueiro, J. L., Richardson, J. A. et al. (1996) T cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic rats. J. Immunol. 156, 794-803
54. Taurog, J. D., Richardson, J. A., Croft, J. T. et al. (1994) The germ free state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J. Exp. Med. 180, 2359-2364
55. Khare, S. D., Luthra, H. S. and David, C. S. (1995) Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta(2)-microglobulin: a model of human spondyloarthropathies. J. Exp. Med. 182, 1153-1158
56. Khare, S. D., Hansen, J., Luthra, H. S. and David, C. S. (1996) HLA-B27 heavy chains contribute to spontaneous inflammatory disease in B27/human beta(2)-microglobulin (beta(2)m) double transgenic mice with disrupted mouse beta(2)m. J. Clin. Invest. 98, 2746-2755
57. Holmdahl, R., Klareskog, L., Rubin, K. et al. (1986) Role of T lymphocytes in murine collagen induced arthritis. Agents Actions 19, 295-305
58. Giant, T., Mikecz, K., Arzoumanian, A. and Poole, A. (1987) Proteoglycan induced arthritis in BALB/c mice. Clinical features and histopathology. Arthritis Rheum. 30, 201-212
59. Verheijden, G. F. M., Rijnders, A. W. M., Bos, E. et al. (1997) Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis. Arthritis Rheum. 40, 1115-1125
60. Holmdahl, R., Karlsson, M., Andersson, M., Rask, L. and Andersson, L. (1989) Localization of a critical restriction site on the I-Ab chain that determines susceptibility to collageninduced arthritis in mice. Proc. Natl. Acad. Sci. U.S.A. 86, 9475-9479
61. Mitchison, N. A. and Brunner, M. C. (1995) Association of H2A(b) with resistance to collagen-induced arthritis in H2-recombinant mouse strains: an allele associated with reduction of several apparently unrelated responses. Immunogenetics 41, 239-245
62. Brunsberg, U., Gustafsson, K., Jansson, L. et al. (1994) Expression of a transgenic class II Ab gene confers susceptibility to collagen-induced arthritis. Eur. J. Immunol. 24, 1698-1702
63. Gulko, P., Griffiths, M., Kawahito, Y. et al. Genome-wide scan identifies a non-MHC chromosome 2 locus controlling collagen-induced arthritis (CIA) severity. Arthritis Rheum. (1997) 41,S159
64. Lorentzen, J. C. and Klareskog, L. (1996) Susceptibility of DA rats to arthritis induced with adjuvant oil or rat collagen is determined by genes both within and outside the major histocompatibility complex. Scand. J. Immunol. 44, 592-598
65. Seki, N., Sudo, Y., Yoshioka, T. et al. (1988) Type II collagen induced murine arthritis. 1. Induction and perpetuation of arthritis require synergy between humoral and cell mediated immunity. J. Immunol. 140, 1477-1484
66. Banerjee, S., Wei, B., Hillman, K., Luthra, H. and David, C. (1988) Immunosuppression of collagen induced arthritis in mice with an anti IL-2 receptor antioody. J. Immunol. 141, 1150-1154
67. Durie, F. H., Fava, R.A, Foy, T. M., Aruffo, A., Ledbetter, J. A. and Noelle, R. J. (1993) Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science (Washington DC) 261, 1328-1330
68. Goldschmidt, T. and Holmdahl, R. (1991) Anti T-cell receptor antibody treatment of rats with established autologous collagen induced arthritis: suppression of arthritis without reduction of anti type II collagen autoantibody levels. Eur. J. Immunol. 21, 1327-1330
69. Haqqi, T. M., Qu, X. M., Anthony, D., Ma, J. and Sy, M. S. (1996) Immunization with T cell receptor V beta chain peptides deletes pathogenic T cells and prevents the induction of collagen-induced arthritis in mice. J. Clin. Invest. 97, 2849-2858
70. Kumar, V., Aziz, F., Sercarz, E. and Miller, A. (1997) Regulatory T cells specific for the same framework 3 region of the V beta 8.2 chain are involved in the control of collagen II-induced arthritis and experimental autoimmune encephalomyelitis. J. Exp. Med. 185, 1725-1733
71. Webb, L. M. C., Walmsley, M. J. and Feldmann, M. (1996) Prevention and amelioration of collagen-induced arthritis by blockade of the CD28 co-stimulatory pathway: requirement for both B7-1 and B7-2. Eur. J. Immunol. 26, 2320-2328
72. Snowden, N., Reynolds, I., Morgan, K. and Holt, L. (1997) T cell responses to human type II collagen in patients with rheumatoid arthritis and healthy controls. Arthritis Rheum. 40, 1210-1218
73. Londei, M., Savill, C., Verhoef, A. et al. (1989) Persistence of collagen type II specific T cell clones in the synovial membrane of a patient with rheumatoid arthritis. Proc. Natl. Acad. Sci. U.S.A. 86, 636-640
74. Ronnelid, J., Lysholm, J., Engstromlaurent, A., Klareskog, L. and Heyman, B. (1994) Local anti-type II collagen antibody production in rheumatoid arthritis synovial fluid -evidence for an HLA-DR4-restricted IgG response. Arthritis Rheum. 37, 1023-1029
75. Trentham, D. E., Dynesiustrentham, R. A., Orav, E. J. et al. (1993) Effects of oral administration of type-II collagen on rheumatoid arthritis. Science (Washington DC) 261, 1727-1730
76. Thompson, H. and Staines, N. (1986) Gastric administration of type II collagen delays the onset and severity of collagen induced arthritis in rats. Clin. Exp. Immunol. 64, 581-586
77. Nagler, A. C., Bober, L., Robinson, M., Siskind, G. and Thorbecke, G. (1986) Suppression of type II collagen induced arthritis by intragastric administration of soluble type II collagen. Proc. Natl. Acad. Sci. U.S.A. 83, 7443-7446
78. Sieper, J., Kary, S., Sorensen, H. et al. (1996) Oral type II collagen treatment in early rheumatoid arthritis: a doubleblind, placebo-controlled, randomized trial. Arthritis Rheum. 39, 41-51
79. Goodacre, J. A. and Pearson, J. P. (1992) Human cartilage proteoglycans as T cell autoantigens. Ann. Rheum. Dis. 51, 1094-1097
80. Buzas, E.I, Brennan, F. R., Mikecz, K. et al. (1995) A proteoglycan (aggrecan)-specific T cell hybridoma induces arthritis in BALB/c mice. J. Immunol. 155, 2679-2687
81. Leroux, J. Y., Guerassimov, A., Cartman, A. et al. (1996) Immunity to the G1 globular domain of the cartilage proteoglycan aggrecan can induce inflammatory erosive polyarthritis and spondylitis in BALB/c mice but immunity to G1 is inhibited by covalently bound keratan sulfate in vitro and in vivo. J. Clin. Invest. 97, 621-632
82. Mikecz, K., Glant, T., Baron, M. and Poole, A. (1988) Isolation of proteoglycan specific T lymphocytes from patients with ankylosing spondylitis. Cell Immunol. 112, 55-63
83. Alsalameh, S., Glant, T., Al-Ward, R., Manger, B., Al-Almiri, H. and Kalden, J. (1997) Cartilage proteoglycan (aggrecan)-specific T cell response in patients with rheumatoid arthritis. Arthritis Rheum. 40, S37
84. Tisch, R. and McDevitt, H. (1996) Insulin-dependent diabetes mellitus. Cell 85, 291-297
85. Kouskoff, V., Korganow, A. S., Duchatelle, V., Degott, C., Benoist, C. and Mathis, D. (1996) Organ-specific disease provoked by systemic autoimmunity. Cell 87, 811-822
86. Keffer, J., Probert, L., Cazlaris, H., et al. (1991) Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J. 10, 4025-4031
87. Fearon, D. (1997) Seeking wisdom in innate immunity. Nature (London) 388, 323
88. Matzinger, P. (1994) Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991-1045
89. vanEden, W., Hogervorst, E., Hensen, E., vanderZee, R., vanEmbden, J. and Cohen, I. (1989) A cartilage mimicking T cell epitope on a 65 K mycobacterial heat shock protein: adjuvant arthritis as a model for human rheumatoid arthritis. Curr. Top. Microbiol. Immunol. 145, 27-43
90. Kleinau, S., Erlandsson, H. and Klareskog, L. (1994) Percutaneous exposure of adjuvant oil causes arthritis in DA rats. Clin. Exp. Immunol. 96, 281-284
91. Billingham, M., Carney, S., Butler, R. and Colston, M. (1990) A mycobacterial 65 kD heat shock protein induces antigen specific suppression of adjuvant arthritis, but is not itself arthritogenic. J. Exp. Med. 171, 339-44
92. Bedwell, A., Elson, C. and Hinton, C. (1987) Immunological involvement in the pathogenesis of pristanc induced arthritis. Scand. J. Immunol. 25, 393-398
93. Hughes, R. A., Allard, S. A. and Maini, R. N. (1988) Arthritis associated with adjuvant mycobacterial treatment for carcinoma of the bladder. Ann. Rheum. Dis. 48, 432-434
94. Goupille, P., Soutif, D. and Valat, J. P. (1992) Arthritis after Calmette-Guerin Bacillus immunotherapy for bladder cancer. J. Rheumatol. 19, 1825-1826
95. Miossec, P. (1996) Reactive arthritis associated with bacillus Calmette-Guerin immunotherapy for carcinoma of the bladder: immune reactivity against mycobacterial antigens. J. Rheumatol. 23, 1485
96. Gaston, J., Young, J., Ramsey, S. and Scott, D. (1996) Specificity of synovial fluid T cells in iatrogenic human adjuvant arthritis. Arthritis Rheum. 39, S149
97. Gough, A., Faint, J., Salmon, M., et al. (1994) Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome. Arthritis Rheum. 37, 1166-1170
98. Kalish, R., Leong, J. and Steere, A. (1993) Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect. Immun. 61, 2774-2779
99. vanEden, W., Thole, J., vanderZee, R., et al. (1988) Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature (London) 331, 171-173
100. Anderton, S. M., vanderZee, R., Noordzij, A. and vanEden, W. (1994) Differential mycobacterial 65-kDa heat shock protein T cell epitope recognition after adjuvant arthritisinducing or protective immunization protocols. J. Immunol. 152, 3656-3664
101. Anderton, S. M., vanderZee, R., Prakken, B., Noordzij, A. and vanEden, W. (1995) Activation of T cells recognizing self 60-kD heat shock protein can protect against experimental arthritis. J. Exp. Med. 181, 943-952
102. Anderton, S. M., vanderZee, R. and Goodacre, J. A. (1993) Inflammation activates self hsp60-specific T-cells. Eur. J. Immunol. 23, 33-38
103. Elias, D., Meilin, A., Ablamunits, V. et al. (1997) Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various beta-cell antigens. Diabetes 46, 758-764
104. vandenBroek, M., Hogervorst, E., vanBruggen, M., vanEden, W., vanderZee, R. and vandenBerg, W. (1989) Protection against streptococcal cell wall induced arthritis by pretreatment with the 65 kD mycobacterial heat shock protein. J. Exp. Med. 170, 449-466
105. Ghoraishian, M., Elson, C. J. and Thompson, S. J. (1993) Comparison between the protective effects of mycobacterial 65-kD heat shock protein and ovomucoid in pristane-induced arthritis - relationship with agalactosyl IgG. Clin. Exp. Immunol. 94, 247-251
106. Prakken, A., vanEden, W., Rijkers, G. et al. (1996) Autorcactivity to human heat shock protein 60 predicts disease remission in oligoarticular juvenile rheumatoid arthritis. Arthritis Rheum. 39, 1826-1832
107. Birk, O., Douek, D., Elias, D. et al. (1996) A role of hsp60 in autoimmune diabetes: analysis in a transgenic model. Proc. Natl. Acad. Sci. U.S.A. 93, 1032-1037
108. Elias, D., Markovits, D., Reshef, T., vanderZee, R. and Cohen, I. (1990) Induction and therapy of autoimmune diabetes in the non obese diabetic (NOD/Lt) mouse by a 65 kDa heat shock protein. Proc. Natl. Acad. Sci. U.S.A. 87, 1576-1580
109. Cohen, I. (1991) Autoimmunity to chaperonins in the pathogenesis of arthritis and diabetes. Annu. Rev. Immunol. 9, 567-589
110. Cohen, I. R. (1997) The Th1/Th2 dichotomy, hsp60 autoimmunity, and type I diabetes. Clin. Immunol. Immunopathol. 84, 103-106
111. Fowell, D. and Mason, D. (1993) Evidence that the T cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization of the CD4 + T cell subset that inhibits this autoimmune potential. J. Exp. Med. 177, 627-636
112. Bell, E. and Sparshott, S. (1990) Interconversion of CD45R subsets of CD4 T cells in vivo. Nature (London) 348, 163-166
113. Powrie, F., Correaoliveira, R., Mauze, S. and Coffman, R. L. (1994) Regulatory interactions between CD45RB(high) and CD45RB(low) CD4( + ) T cells are important for the balance between protective and pathogenic cellmediated immunity. J. Exp. Med. 179, 589-600
114. Wicker, L., Appel, M., Dotta, F. et al. (1992) Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophos-phamide-induced diabetes. J. Exp. Med. 176, 67-77
115. Saoudi, A., Seddon, B., Heath, V., Fowell, D. and Mason, D. (1996) The physiological role of regulatory T cells in the prevention of autoimmunity : the function of the thymus in the generation of the regulatory T cell subset. Immunol. Rev. 149, 195-216
116. Vandenbark, A., Chou, Y., Bourdette, D., Whitham, R., Hashim, G. and Offner, H. (1992) T cell receptor peptide therapy for autoimmune disease. J Autoimmun. 5 (Suppl. A), 83-92